Truist analyst Srikripa Devarakonda notes that AbbVie (ABBV) announced negative trial results for emraclidine in dual Phase 2 schizophrenia ...
Stocks rose to record highs again Monday, while bitcoin hit all-time highs of its own above $86,000, as the election-fueled rally continues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback